October 18-20 | Tucson, AZ

The Research Institution GAP Fund and Accelerator Program Summit

The University of Tennessee Research Foundation has selected Orion Therapeutics as the first recipient of its $5 million fund | Knoxville News Sentinel

Get our GAP Insights Newsletter

Join Us

October 23-25, 2024 / Atlanta, GA

The annual summit for research institution gap fund and accelerator programs, including proof of concept programs, startup accelerators, and university venture funds

The Story

The University of Tennessee Research Foundation has selected Orion Therapeutics as the first recipient of its $5 million fund to support startups that bring research from the university’s labs to the market.

Orion is developing a new way to deliver drugs that use ribonucleic acid, or RNA, to new places in the body. RNA, the single-strand cousin of DNA, is increasingly used in medicines and vaccines to treat conditions ranging from muscular dystrophy to COVID-19.

Orion’s technology focuses on vascular diseases, such as dangerous buildup of plaque in arteries. It was founded in 2022 by a UT medical professor and her former graduate student.

Full story: News | Knoxville News Sentinel

Get the Report

More GAP News